Under government pricing pressure, U.K. drugmakers threatened to move away and Novartis invoked the old "loss of innovation" argument. Indian drugmakers are putting those protests to shame: Raise the prices on 33 bulk drugs immediately, they're telling the government, or we'll have to stop making them altogether. Report